Novel Agents Up For US FDA Approval In 2025

 
• By Bridget Silverman, Nancy Pham, and Kosh Naran
  
The FDA's 2025 user fee calendar includes a wide range of product types. (Shutterstock)

More from Pink Sheet Perspectives

More from Regulatory Trackers